tiprankstipranks
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market

KalVista Pharmaceuticals (KALV) Technical Analysis

Compare
405 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
KalVista Pharmaceuticals’s (KALV) Moving Averages Convergence Divergence (MACD) indicator is 0.39, suggesting KalVista Pharmaceuticals is a Sell.
KalVista Pharmaceuticals’s (KALV) 20-Day exponential moving average is 9.49, while KalVista Pharmaceuticals’s (KALV) share price is $10.64, making it a Buy.
KalVista Pharmaceuticals’s (KALV) 50-Day exponential moving average is 9.33, while KalVista Pharmaceuticals’s (KALV) share price is $10.64, making it a Buy.

KalVista Pharmaceuticals (KALV) Pivot Points

Feb 21, 2025, 05:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.54
9.09
9.90
10.45
11.26
11.81
12.62
Fibonacci
9.09
9.61
9.93
10.45
10.97
11.29
11.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

KalVista Pharmaceuticals (KALV) Moving Averages

Feb 21, 2025, 05:10 PM
Period
Simple
Exponential
MA5
10.08Buy
10.19Buy
MA10
9.70Buy
9.85Buy
MA20
9.37Buy
9.49Buy
MA50
8.90Buy
9.33Buy
MA100
9.92Buy
9.83Buy
MA200
11.12Sell
10.76Sell
KalVista Pharmaceuticals’s (KALV) 10-Day exponential moving average is 9.85, while KalVista Pharmaceuticals’s (KALV) share price is $10.64, making it a Buy.
KalVista Pharmaceuticals’s (KALV) 100-Day exponential moving average is 9.83, while KalVista Pharmaceuticals’s (KALV) share price is $10.64, making it a Buy.
KalVista Pharmaceuticals’s (KALV) stock price is $10.64 and KalVista Pharmaceuticals’s (KALV) 50-day simple moving average is 8.90, creating a Buy signal.
KalVista Pharmaceuticals’s (KALV) stock price is $10.64 and KalVista Pharmaceuticals’s (KALV) 100-day simple moving average is 9.92, creating a Buy signal.
KalVista Pharmaceuticals’s (KALV) stock price is $10.64 and KalVista Pharmaceuticals’s (KALV) 200-day simple moving average is 11.12, creating a Sell signal.

KalVista Pharmaceuticals (KALV) Technical Indicators

Feb 21, 2025, 05:10 PM
Name
Value
Implied Action
RSI (14)
70.73
Sell
STOCH (9,6)
81.31
Sell
STOCHRSI (14)
83.78
Sell
MACD (12,26)
0.39
Sell
ADX (14)
23.29
Neutral
Williams %R
-15.45
Sell
CCI (14)
190.14
Sell
ATR (14)
0.53
-
Ultimate Oscillator
67.23
Neutral
ROC
21.32
Buy
KalVista Pharmaceuticals’s (KALV) Relative Strength Index (RSI) is 70.73, creating a Sell signal.
KalVista Pharmaceuticals’s (KALV) Trend Strength Indicator (ADX) is 23.29, creating a Neutral signal.
KalVista Pharmaceuticals’s (KALV) Commodity Channel Index (CCI) is 190.14, creating a Sell signal.
KalVista Pharmaceuticals’s (KALV) Price Rate of Change (ROC) is 21.32, creating a Buy signal.

FAQ

Is KALV a Buy, Hold, or Sell?
Based on KALV’s technical indicators, KALV is a Buy.
    What is KALV’s RSI (14)?
    KALV’s RSI (14) is 70.73, which suggests KALV is a Sell.
      What is KALV’s MACD?
      KALV’s MACD is 0.39, which suggests KALV is a Sell.
        What is KALV’s 5-day moving average?
        KALV’s 5-day moving average is 10.08, which suggests KALV is a Buy.
          What is KALV’s 20-day moving average?
          KALV 20-day moving average is 9.37, which suggests KALV is a Buy.
            What is KALV’s 50-day moving average?
            KALV’s 50-day moving average is 8.90, which suggests KALV is a Buy.
              What is KALV’s 200-day moving average?
              KALV’s 200-day moving average is 11.12, which suggests KALV is a Sell.
                What is KALV’s Williams % R (14)?
                KALV’s Williams % R (14) is -15.45, which suggests KALV is a Sell.
                  What is KALV’s CCI (14)?
                  KALV’s CCI (14) is 190.14, which suggests KALV is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis